Who are Split-dose low-volume PEG's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Cool prep, Polyethylene Glycol-Based Lavage.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/split-dose-low-volume-peg.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Split-dose low-volume PEG — Competitive Intelligence Brief

Split-dose low-volume PEG (Split-dose low-volume PEG) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative / bowel preparation agent. Area: Gastroenterology.

marketed Osmotic laxative / bowel preparation agent Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Split-dose low-volume PEG (Split-dose low-volume PEG) — Kyunghee University Medical Center. Split-dose low-volume polyethylene glycol (PEG) solution reduces bowel preparation volume while maintaining efficacy by dividing the dose into smaller administrations.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Split-dose low-volume PEG TARGET	Split-dose low-volume PEG	Kyunghee University Medical Center	marketed	Osmotic laxative / bowel preparation agent
Cool prep	Cool prep	Taejoon Pharmaceutical Co., Ltd.	phase 3	Osmotic laxative / Bowel preparation agent
Polyethylene Glycol-Based Lavage	Polyethylene Glycol-Based Lavage	University of Calgary	phase 3	Osmotic laxative / Bowel preparation agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic laxative / bowel preparation agent class)

Kyunghee University Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Split-dose low-volume PEG — Competitive Intelligence Brief. https://druglandscape.com/ci/split-dose-low-volume-peg. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab